All posts tagged
This Small German Biotech is Dealing with Big Pharma in NASH and Autoimmune Disease
The Advantage for the First Mover in NASH is Limited, says Genfit
French Hepatitis Cure is on Track with Positive Phase I Results
Meet the Swedish Biotech that is Tackling NASH Through Mitochondria
French Biotech gets a Second Opportunity to Fight Liver Fibrosis
Genfit Delays Phase III Enrollment in the Race for the First NASH Therapy
Two Big Pharma Players Team up to Take Over the NASH Space
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
More News! Smart Lens looks More Distant & a Pollen Allergy Cure?
French Biotech gets a Boost in the NASH Race with a Successful IPO
Not to be Underestimated: What’s the Hype around NASH?
Top European VC and CRO fund Young Metabolic Disease Biotech
Labiotech UG, All Rights Reserved -
Send this to friend